Clinical Trial: Hyperbaric oxygen therapy for covert hepatic encephalopathy (CHE) in patients with liver cirrhosis: a prospective, randomized controlled, open-label clinical trial (China)

Posted On: 2026-09-11

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Hyperbaric oxygen therapy for covert hepatic encephalopathy (CHE) in patients with liver cirrhosis: a prospective, randomized controlled, open-label clinical trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132142

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: Army Medical Center of PLA

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339983

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Hyperbaric oxygen therapy for covert hepatic encephalopathy (CHE) in patients with liver cirrhosis: a prospective, randomized controlled, open-label clinical trial (China)